olprinone has been researched along with Arrhythmia in 1 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "We concluded that TWBCP with olprinone reduces myocardial reperfusion injury by reducing oxidant-mediated lipid peroxidation, and it accelerates prompt and persistent LV functional recovery with suppression of reperfusion arrhythmia." | 3.78 | Reversal of oxidant-mediated biochemical injury and prompt functional recovery after prolonged single-dose crystalloid cardioplegic arrest in the infantile piglet heart by terminal warm-blood cardioplegia supplemented with phosphodiesterase III inhibitor. ( Abe, T; Hashimoto, K; Kinouchi, K; Ko, Y; Morita, K; Nagahori, R; Shinohara, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinouchi, K | 1 |
| Morita, K | 1 |
| Ko, Y | 1 |
| Nagahori, R | 1 |
| Shinohara, G | 1 |
| Abe, T | 1 |
| Hashimoto, K | 1 |
1 other study available for olprinone and Arrhythmia
| Article | Year |
|---|---|
Reversal of oxidant-mediated biochemical injury and prompt functional recovery after prolonged single-dose crystalloid cardioplegic arrest in the infantile piglet heart by terminal warm-blood cardioplegia supplemented with phosphodiesterase III inhibitor.
Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Biomarkers; Cyclic AMP; Disease Models, Animal; Hea | 2012 |